IntegraGen of Paris has raised $9.6 million in its second round of venture capital. The company is developing genetic tests for complex diseases, with a focus on diabetes, autism and obesity. IntegraGen is currently conducting diabetes testing in Bonn, Germany.
- read this press release for more information